{"id":"W2784429314","doi":"10.1371/journal.pmed.1002482","title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study","year":2018,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":499,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"U.S. National Library of Medicine; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Institutes of Health; Eisai; Cognoptix; BioClinica; U.S. Department of Defense; Alzheimer's Disease Neuroimaging Initiative; Northern California Institute for Research and Education; F. Hoffmann-La Roche; University of Southern California; Biogen; Eli Lilly and Company; Bristol-Myers Squibb; National Institute on Aging; Alzheimer's Association; Foundation for the National Institutes of Health","keywords":"Neuropathology; Medicine; Alzheimer's disease; Alzheimer's Disease Neuroimaging Initiative; Neuroimaging; Disease; Internal medicine; Biomarker; Metabolomics; Pathology; Dementia; Neurology; Oncology; Physiology; Bioinformatics; Biology; Psychiatry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01346814717243022,"score_gpt":0.2856852330316198,"score_spread":0.2722170858591896,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}